Trial Profile
SIB-GBM trial (Simultaneous Integrated Boost in Glioblastoma multiforme: hyprofractionated radiotherapy with concomitant boost and temozolomide, in glioblastoma RPA III and IV patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms SIB-GBM trial
- 30 Jun 2014 New trial record